Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

273 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Concordance Between Recommendations From Multidisciplinary Molecular Tumor Boards and Central Consensus for Cancer Treatment in Japan.
Naito Y, Sunami K, Kage H, Komine K, Amano T, Imai M, Koyama T, Ennishi D, Kanai M, Kenmotsu H, Maeda T, Morita S, Sakai D, Watanabe K, Shirota H, Kinoshita I, Yoshioka M, Mamesaya N, Ito M, Kohsaka S, Saigusa Y, Yamamoto K, Hirata M, Tsuchihara K, Yoshino T. Naito Y, et al. Among authors: kenmotsu h. JAMA Netw Open. 2022 Dec 1;5(12):e2245081. doi: 10.1001/jamanetworkopen.2022.45081. JAMA Netw Open. 2022. PMID: 36469316 Free PMC article.
Efficacy of prophylactic cranial irradiation in patients with limited-disease small-cell lung cancer who were confirmed to have no brain metastasis via magnetic resonance imaging after initial chemoradiotherapy.
Mamesaya N, Wakuda K, Omae K, Miyawaki E, Kotake M, Fujiwara T, Kawamura T, Kobayashi H, Nakashima K, Omori S, Ono A, Kenmotsu H, Naito T, Murakami H, Mori K, Harada H, Endo M, Nakajima T, Takahashi T. Mamesaya N, et al. Among authors: kenmotsu h. Oncotarget. 2018 Apr 3;9(25):17664-17674. doi: 10.18632/oncotarget.24830. eCollection 2018 Apr 3. Oncotarget. 2018. PMID: 29707139 Free PMC article.
Clinical and radiation dose-volume factors related to pneumonitis after treatment with radiation and durvalumab in locally advanced non-small cell lung cancer.
Inoue H, Ono A, Kawabata T, Mamesaya N, Kawamura T, Kobayashi H, Omori S, Wakuda K, Kenmotsu H, Naito T, Murakami H, Yasui K, Ogawa H, Onoe T, Endo M, Harada H, Takahashi T. Inoue H, et al. Among authors: kenmotsu h. Invest New Drugs. 2020 Oct;38(5):1612-1617. doi: 10.1007/s10637-020-00917-2. Epub 2020 Mar 3. Invest New Drugs. 2020. PMID: 32128667 Free PMC article.
Association Between Clinical Tumor Burden and Efficacy of Immune Checkpoint Inhibitor Monotherapy for Advanced Non-Small-Cell Lung Cancer.
Miyawaki T, Kenmotsu H, Mori K, Miyawaki E, Mamesaya N, Kawamura T, Kobayashi H, Omori S, Wakuda K, Ono A, Naito T, Murakami H, Harada H, Endo M, Ohde Y, Takahashi K, Takahashi T. Miyawaki T, et al. Among authors: kenmotsu h. Clin Lung Cancer. 2020 Sep;21(5):e405-e414. doi: 10.1016/j.cllc.2020.02.012. Epub 2020 Feb 26. Clin Lung Cancer. 2020. PMID: 32205040 Clinical Trial.
Proposing synchronous oligometastatic non-small-cell lung cancer based on progression after first-line systemic therapy.
Miyawaki T, Wakuda K, Kenmotsu H, Miyawaki E, Mamesaya N, Kobayashi H, Omori S, Ono A, Naito T, Murakami H, Notsu A, Mori K, Harada H, Endo M, Ohde Y, Takahashi K, Takahashi T. Miyawaki T, et al. Among authors: kenmotsu h. Cancer Sci. 2021 Jan;112(1):359-368. doi: 10.1111/cas.14707. Epub 2020 Nov 11. Cancer Sci. 2021. PMID: 33098119 Free PMC article.
Efficacy of pembrolizumab in patients with brain metastasis caused by previously untreated non-small cell lung cancer with high tumor PD-L1 expression.
Wakuda K, Yabe M, Kodama H, Nishioka N, Miyawaki T, Miyawaki E, Mamesaya N, Kawamura T, Kobayashi H, Omori S, Ono A, Kenmotsu H, Naito T, Murakami H, Harada H, Endo M, Gon Y, Takahashi T. Wakuda K, et al. Among authors: kenmotsu h. Lung Cancer. 2021 Jan;151:60-68. doi: 10.1016/j.lungcan.2020.11.009. Epub 2020 Nov 15. Lung Cancer. 2021. PMID: 33246646
273 results